clinicians preference when semaglutide is not suitable Weight maintenance after discontinuation of GLP-1 therapies Semaglutide for Weight Loss: A

Neither pattern indicates treatment failure

Taken together, evidence from the STEP, SURMOUNT, and S-LiTE trials strongly supports the lifestyle interventions, particularly dietary modification and structured exercise, being not only compatible with but also additive to the effects of GLP-1 therapies

And the 14 mg doses likely tracked in the mid-teens

These effects are why sermorelin is often explored for anti-aging purposes, though this remains an off-label use

While Saxenda alone rarely causes low blood sugar, the risk increases if you are taking insulin or sulfonylurea medications for diabetes

Some of these side effects can pose significant health risks